Mandom Corp. engages in the manufacture and sale of cosmetics, fragrance products and quasi-drugs. Its operations are carried out through the following business divisions: Cosmetics and Others. The Cosmetics division provides make-up kits, skin care, body care, hair care, hair colouring, daily grooming, and hair styling products for men and women. The Others division includes insurance agency business and building management services. The company was founded on December 23, 1927 and is headquartered in Osaka, Japan.

Sanovel Ila�� Sanayi ve Ticaret AS engages in the manufacture of pharmaceutical products. It develops medicaments, such as antihistamines, expectorants, decongestants, antibiotics, and anti-inflammatory drugs, as well as offers research and development services. The company was founded by Erol Toks��z in 1983 and is headquartered in Istanbul, Turkey.

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Coty BV, part of Agnaten SE, is a company headquartered in Schiphol-Rijk, the Netherlands. The firm manufactures and markets beauty products, fragrances, color cosmetics and skin care products.

Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD.

Caliway Biopharmaceuticals Co. Ltd. offers pharmaceutical services. It focuses on medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics to help patients suffering from illness or life threatening diseases. The company was founded in 2012 and is headquartered in New Taipei City, Taiwan.

Shanghai Hanwei Biomedical Technology Co., Ltd., established on 2008-08-28, Business scope includes general items:engaged in biomedical technology,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Packaging Materials,Daily necessities,hardware tools,electronics,building materials,handcrafted gift,household products,Decoration material,Sales of pet supplies.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Veterinary drug business;Veterinary drug production;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Yantai Huawenxin Pharmaceutical Technology Co., Ltd., established on 2016-03-09, Business scope includes medical technology development,technical consulting,Technology Promotion,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Mayne Pharma International Pty Ltd., part of Mayne Pharma Group Ltd., is an Australian company. The firm manufactures and distributes pharmaceutical products. It was acquired by Halcygen Pharmaceuticals Ltd. from Hospira, Inc. on October 30, 2009 for $15.00 million.

King Pharmaceuticals, Inc. (King) is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products and animal health products. King's branded prescription pharmaceuticals include neuroscience products (primarily pain medicines), hospital products and legacy brands, all of which are for use in humans. Its auto-injector business manufactures acute care medicines for use in humans that are delivered using an auto-injector. Its animal health business is focused on medicated feed additives (MFAs) and water-soluble therapeutics primarily for poultry, cattle and swine. King's business consists of four segments: a specialty-driven branded prescription pharmaceuticals business, global animal health business, Meridian auto-injector business, and royalties and other.

Estechpharma Co., Ltd. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. Its products include treatment of alcoholism, anti-inflammatory, analgesics, muscle relaxant, antiseptic, antispasmodics, anti-cataracts, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, antihistamine, nootropic and anti-diabetics. The company was founded on December 17, 1998 and is headquartered in Hwaseong, South Korea.

Shandong Yuxin Pharmaceutical Co., Ltd., established on 2010-12-30, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Disinfectant production(Free of Hazardous Chemicals);Catering Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Pharmaceutical commissioned production;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of labor protection products;Sales of labor protection products;Disinfectant sales(Free of Hazardous Chemicals);Medical Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Yuhan Corp. engages in the manufacture of pharmaceutical, health foods, cosmetics and consumer products. It operates through the following business areas: Pharmaceutical, Household products and Active Pharmaceutical Ingredient (API). Its products include APIs and intermediates and finished products such as ethical drugs, over-the-counter drugs and others. Its services include custom development and manufacturing services and supply chain management. The company was founded by Il-Han New on June 20, 1926 and is headquartered Seoul, South Korea.

Suzhou Proda Biotechnology Co., Ltd., established on 2012-12-22, Business scope includes biomedicine,Health products,food,cosmetic,medical instruments,Non-hazardous chemical products,Research and development of sewage treatment technology,Technical cooperation,technical consulting,technology transfer;Sales:Non-hazardous chemical products,Class I medical device,cosmetic.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Yonsung Fine Chemicals Co., Ltd. is a South Korean private company located in Hwaseong-si, also operating in Germany, that manufactures pharmaceuticals and chemical products. It was founded in 2001 by Won-Hun Ham and Chang-Yeong Oh. Chang-Yeong Oh has been the CEO since the inception date.

Cycle Pharmaceuticals is a pioneering pharmaceutical company, reimagining how drugs can benefit patients, to improve the efficacy of their treatments and their quality of life at every stage. They’re not bound by precedent. Instead, they target overlooked areas of medicine, and market imbalance, where they can make an immediate, tangible difference to patients. By addressing treatment issues with cutting-edge expertise and a fresh, bold approach, they make a difference to patients’ lives.Because their investors are long-term thinkers, they can put patients first. They speak to patients, parents, caregivers, healthcare practitioners and patient associations, to ensure that their needs are central to their work. Whether it’s improving under-developed drugs, or supplying markets where demand is increasing prices and restricting access, they're here to get patients the treatment they need.